[Inhibitory effect of LRRC4 on the mobility and invasion of glioblastomas through the SDF-1alpha/CXCR4 axis]

Qiong Chen1, Ming-hua Wu, Yan-hong Zhou

  • 1Cancer Research Institute, Central South University, Changsha 410078, China.

Abstract

Insights

Leucine-rich repeat-containing protein 4 (LRRC4) inhibits glioblastoma cell invasion by downregulating CXCR4 expression and the SDF-1alpha/CXCR4 axis. LRRC4 also enhances intercellular communication in U251 cells.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cell Biology

Context:

  • Glioblastoma multiforme (GBM) is an aggressive brain tumor with poor prognosis.
  • The SDF-1alpha/CXCR4 signaling pathway plays a critical role in glioblastoma cell migration and invasion.
  • Understanding the molecular mechanisms regulating glioblastoma progression is crucial for developing effective therapies.

Purpose:

  • To investigate the role of Leucine-rich repeat-containing protein 4 (LRRC4) in regulating the mobility and invasion of U251 glioblastoma cells.
  • To elucidate the involvement of the SDF-1alpha/CXCR4 axis in LRRC4-mediated effects on glioblastoma cells.
  • To assess the impact of LRRC4 on U251 cell adhesion, migration, and invasion in vitro.

Summary:

  • Reintroduction of LRRC4 into U251 glioblastoma cells significantly inhibited cell invasion and migration.
  • LRRC4 was found to downregulate the expression of CXCR4, a key receptor in the SDF-1alpha/CXCR4 axis.
  • LRRC4 suppressed U251 cell adhesion to ECV304 cells and enhanced gap junctional intercellular communication.

Impact:

  • LRRC4 acts as a potential tumor suppressor in glioblastoma by inhibiting cell invasion and metastasis.
  • Targeting the SDF-1alpha/CXCR4 axis, potentially modulated by LRRC4, could offer a therapeutic strategy for glioblastoma.
  • The findings highlight LRRC4's multifaceted role in regulating glioblastoma cell behavior and intercellular communication.